• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

突尼斯耐多药结核病治疗失败的危险因素:一项分析性研究。

Risk factors for treatment failure in multidrug resistant tuberculosis in Tunisia: An analytic study.

机构信息

Pulmonary department (C), Abderrahman Mami Hospital, Tunisia.

Tunis El Manar University.

出版信息

Tunis Med. 2024 Jan 5;102(1):44-48. doi: 10.62438/tunismed.v102i1.4521.

DOI:10.62438/tunismed.v102i1.4521
PMID:38545729
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11261501/
Abstract

INTRODUCTION-AIM: The emergence of multidrug resistant tuberculosis (MDR-TB) is a threat to global public health. The aim of our study was to determine risk factors for treatment failure in MDR-TB.

METHODS

Retrospective study conducted between January 2000 and March 2019 including patients with MDR-TB. Characteristics of patients with therapeutic failure were compared to cured ones. Logistic regression analysis was used to identify risk factors for treatment failure.

RESULTS

Our study included 140 patients aged of 42±13 years (18-80). Fifty-seven percent of patients had treatment success and 12% had treatment failure. In multivariate logistic regression analysis, treatment failure was associated with age over 45 years (OR=1.05; 95%CI, 1.024-7.736;p=0.014), primary education level and illiteracy (OR=5.022; 95%CI, 1.316-19.161;p=0,018), history of incarceration (OR=3.291; 95%CI, 1.291-21.083;p=0.016), undernutrition (OR=4.544; 95%CI, 2.304-54.231;p=0,027), extensive TB (OR=6.406; 95%CI, 1.761-23.922; p=0.038), initial high grade positive smears (OR=1.210; 95%CI, 1.187-32.657; p=0.045), positive smear culture at 90 days of treatment (OR=6.871, 95%CI, 3.824-23.541; p=0.003), poor adherence (OR=6.110; 95%CI, 2.740-12.450; p=0.021) and occurrence of psychiatric adverse events (OR=3.644 95%CI, 2.560- 27.268; p=0.041).

CONCLUSION

Therapeutic education, nutritional and psychological support and close follow-up are strongly recommended to optimize the prognosis of MDR-TB.

摘要

简介-目的:耐多药结核病(MDR-TB)的出现对全球公共卫生构成威胁。本研究的目的是确定 MDR-TB 治疗失败的危险因素。

方法

这是一项回顾性研究,于 2000 年 1 月至 2019 年 3 月进行,纳入 MDR-TB 患者。将治疗失败患者的特征与治愈患者进行比较。使用逻辑回归分析确定治疗失败的危险因素。

结果

本研究共纳入 140 例年龄为 42±13 岁(18-80 岁)的患者。57%的患者治疗成功,12%的患者治疗失败。多变量逻辑回归分析显示,年龄>45 岁(OR=1.05;95%CI,1.024-7.736;p=0.014)、小学及以下文化程度和文盲(OR=5.022;95%CI,1.316-19.161;p=0.018)、入狱史(OR=3.291;95%CI,1.291-21.083;p=0.016)、营养不良(OR=4.544;95%CI,2.304-54.231;p=0.027)、广泛结核病(OR=6.406;95%CI,1.761-23.922;p=0.038)、初始高等级阳性涂片(OR=1.210;95%CI,1.187-32.657;p=0.045)、治疗 90 天阳性涂片培养(OR=6.871,95%CI,3.824-23.541;p=0.003)、依从性差(OR=6.110;95%CI,2.740-12.450;p=0.021)和出现精神科不良事件(OR=3.644,95%CI,2.560-27.268;p=0.041)与治疗失败相关。

结论

强烈建议进行治疗教育、营养和心理支持以及密切随访,以优化 MDR-TB 的预后。

相似文献

1
Risk factors for treatment failure in multidrug resistant tuberculosis in Tunisia: An analytic study.突尼斯耐多药结核病治疗失败的危险因素:一项分析性研究。
Tunis Med. 2024 Jan 5;102(1):44-48. doi: 10.62438/tunismed.v102i1.4521.
2
Treatment outcomes of patients with multidrug-resistant and extensively drug resistant tuberculosis in Hunan Province, China.中国湖南省耐多药和广泛耐药结核病患者的治疗结果
BMC Infect Dis. 2017 Aug 16;17(1):573. doi: 10.1186/s12879-017-2662-8.
3
Risk factors of multidrug resistant tuberculosis among patients with tuberculosis at selected multidrug resistance treatment initiative centres in southern Ethiopia: a case-control study.在埃塞俄比亚南部选定的耐多药结核病治疗倡议中心治疗的结核病患者中耐多药结核病的危险因素:一项病例对照研究。
BMJ Open. 2023 Jan 13;13(1):e061836. doi: 10.1136/bmjopen-2022-061836.
4
Risk factors for the occurrence of multidrug-resistant tuberculosis among patients undergoing multidrug-resistant tuberculosis treatment in East Shoa, Ethiopia.埃塞俄比亚东绍阿地区耐多药结核病治疗患者中出现耐多药结核病的危险因素。
BMC Public Health. 2018 Apr 2;18(1):422. doi: 10.1186/s12889-018-5371-3.
5
Later emergence of acquired drug resistance and its effect on treatment outcome in patients treated with Standard Short-Course Chemotherapy for tuberculosis.接受标准短程化疗的结核病患者中获得性耐药的后期出现及其对治疗结果的影响。
BMC Pulm Med. 2016 Feb 4;16:26. doi: 10.1186/s12890-016-0187-3.
6
Risk factors associated with multidrug-resistant tuberculosis (MDR-TB) in a tertiary armed force referral and teaching hospital, Ethiopia.与埃塞俄比亚一家三级武装部队转诊和教学医院的耐多药结核病(MDR-TB)相关的风险因素。
BMC Infect Dis. 2018 May 31;18(1):249. doi: 10.1186/s12879-018-3167-9.
7
Treatment outcomes in multidrug resistant tuberculosis-human immunodeficiency virus Co-infected patients on anti-retroviral therapy at Sizwe Tropical Disease Hospital Johannesburg, South Africa.南非约翰内斯堡锡兹韦热带病医院接受抗逆转录病毒治疗的耐多药结核病合并人类免疫缺陷病毒感染患者的治疗结果
BMC Infect Dis. 2015 Oct 28;15:478. doi: 10.1186/s12879-015-1214-3.
8
Multidrug-resistant tuberculosis outbreak associated with poor treatment adherence and delayed treatment: Arua District, Uganda, 2013-2017.2013-2017 年乌干达阿鲁阿地区与治疗依从性差和治疗延误相关的耐多药结核病暴发。
BMC Infect Dis. 2019 May 7;19(1):387. doi: 10.1186/s12879-019-4014-3.
9
Treatment outcomes and associated factors among patients with multidrug-resistant tuberculosis in Ashanti Region, Ghana: a retrospective, cross-sectional study.加纳阿散蒂地区耐多药结核病患者的治疗结局和相关因素:一项回顾性、横断面研究。
BMJ Open. 2022 Jul 5;12(7):e062857. doi: 10.1136/bmjopen-2022-062857.
10
Unacceptable treatment outcomes and associated factors among India's initial cohorts of multidrug-resistant tuberculosis (MDR-TB) patients under the revised national TB control programme (2007-2011): Evidence leading to policy enhancement.印度修订国家结核病控制规划(2007-2011 年)下初始耐多药结核病(MDR-TB)患者中不可接受的治疗结果及相关因素:政策改进的依据。
PLoS One. 2018 Apr 11;13(4):e0193903. doi: 10.1371/journal.pone.0193903. eCollection 2018.

本文引用的文献

1
A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis.一项针对耐利福平结核病的较短疗程的试验。
N Engl J Med. 2019 Mar 28;380(13):1201-1213. doi: 10.1056/NEJMoa1811867. Epub 2019 Mar 13.
2
Metformin Use Reverses the Increased Mortality Associated With Diabetes Mellitus During Tuberculosis Treatment.二甲双胍的使用可逆转结核病治疗期间糖尿病相关的死亡率增加。
Clin Infect Dis. 2018 Jan 6;66(2):198-205. doi: 10.1093/cid/cix819.
3
Diabetes Reduces the Rate of Sputum Culture Conversion in Patients With Newly Diagnosed Multidrug-Resistant Tuberculosis.糖尿病降低新诊断的耐多药结核病患者痰培养转阴率。
Open Forum Infect Dis. 2016 Jun 16;3(3):ofw126. doi: 10.1093/ofid/ofw126. eCollection 2016 Sep.
4
Tuberculosis in prisoners and their contacts in Chile: estimating incidence and latent infection.智利囚犯及其接触者中的结核病:发病率和潜伏感染估计
Int J Tuberc Lung Dis. 2016 Jan;20(1):63-70. doi: 10.5588/ijtld.15.0056.
5
Metformin as adjunct antituberculosis therapy.二甲双胍作为辅助抗结核治疗。
Sci Transl Med. 2014 Nov 19;6(263):263ra159. doi: 10.1126/scitranslmed.3009885.
6
[Management of multidrug-resistant tuberculosis].[耐多药结核病的管理]
Rev Pneumol Clin. 2015 Apr-Jun;71(2-3):130-9. doi: 10.1016/j.pneumo.2014.05.001. Epub 2014 Aug 19.
7
[Adjuvant surgical resection for multidrug-resistant tuberculosis: A review].[耐多药结核病的辅助手术切除:综述]
Rev Mal Respir. 2014 Jun;31(6):511-24. doi: 10.1016/j.rmr.2014.01.014. Epub 2014 Apr 18.
8
Antituberculosis drug resistance acquired during treatment: an analysis of cases reported in California, 1994-2006.治疗期间获得的抗结核药物耐药性:1994-2006 年加利福尼亚州报告病例分析。
Clin Infect Dis. 2013 Mar;56(6):761-9. doi: 10.1093/cid/cis989. Epub 2012 Dec 7.
9
Primary disseminated extrapulmonary multidrug resistant tuberculosis.原发性播散性肺外多药耐药结核病
Indian J Med Microbiol. 2012 Jul-Sep;30(3):364-6. doi: 10.4103/0255-0857.99509.
10
[Multi-drug resistance of tuberculosis: 81 patients monitored in an Ivory Coast pneumology unit].[结核病的多重耐药性:在科特迪瓦一家肺病科监测的81例患者]
Rev Pneumol Clin. 2011 Apr;67(2):82-8. doi: 10.1016/j.pneumo.2010.06.002. Epub 2010 Dec 3.